Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	methyl-CpG binding	LRWD1 MBD3L2 MBD3L5 MBD3L3 MBD3L4 MBD3L2B	9.52e-07	31	219	6	GO:0008327
GeneOntologyMolecularFunction	calcium ion binding	DCHS2 CDHR2 F2 FBLN2 HMCN2 HRC PLCD1 PCDH10 ADGRL3 HSPG2 PCDHB15 CAPS PCDHB10 PCDHB9 PCDHB4 PPP3R2 ANKEF1 LPL PCDHGB4 DCHS1 MACF1 DSG4 RAB11FIP3	8.85e-06	749	219	23	GO:0005509
GeneOntologyMolecularFunction	pyruvate kinase activity	PKLR PKM	1.20e-04	2	219	2	GO:0004743
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	DCHS2 CDHR2 HMCN2 PCDH10 PCDHB15 PCDHB10 PCDHB9 PCDHB4 PCDHGB4 DCHS1 DSG4	4.47e-06	187	215	11	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	DCHS2 CDHR2 TAOK2 HMCN2 PTPRS PCDH10 ADGRL3 PCDHB15 PCDHB10 PCDHB9 PCDHB4 PCDHGB4 DCHS1 DSG4	5.60e-06	313	215	14	GO:0098742
GeneOntologyCellularComponent	pyruvate kinase complex	PKLR PKM	1.09e-04	2	219	2	GO:1902912
GeneOntologyCellularComponent	sarcolemma	SGCZ CACNA1H PLEC TRIM72 CACNA1C SYNM FKRP FLOT1 AHNAK2	1.84e-04	190	219	9	GO:0042383
GeneOntologyCellularComponent	basement membrane	ACHE LAMC3 HMCN2 HSPG2 COL7A1 COL18A1 CST3	3.04e-04	122	219	7	GO:0005604
Domain	Cadherin_CS	DCHS2 CDHR2 PCDH10 PCDHB15 PCDHB10 PCDHB9 PCDHB4 PCDHGB4 DCHS1 DSG4	4.81e-07	109	213	10	IPR020894
Domain	MeCpG-bd_2/3_C_dom	MBD3L2 MBD3L5 MBD3L3 MBD3L4	5.60e-07	7	213	4	IPR025884
Domain	MBD2/MBD3_p55-bd	MBD3L2 MBD3L5 MBD3L3 MBD3L4	5.60e-07	7	213	4	IPR032343
Domain	MBDa	MBD3L2 MBD3L5 MBD3L3 MBD3L4	5.60e-07	7	213	4	PF16564
Domain	MBD_C	MBD3L2 MBD3L5 MBD3L3 MBD3L4	5.60e-07	7	213	4	PF14048
Domain	CADHERIN_1	DCHS2 CDHR2 PCDH10 PCDHB15 PCDHB10 PCDHB9 PCDHB4 PCDHGB4 DCHS1 DSG4	6.73e-07	113	213	10	PS00232
Domain	Cadherin	DCHS2 CDHR2 PCDH10 PCDHB15 PCDHB10 PCDHB9 PCDHB4 PCDHGB4 DCHS1 DSG4	6.73e-07	113	213	10	PF00028
Domain	CADHERIN_2	DCHS2 CDHR2 PCDH10 PCDHB15 PCDHB10 PCDHB9 PCDHB4 PCDHGB4 DCHS1 DSG4	7.31e-07	114	213	10	PS50268
Domain	-	DCHS2 CDHR2 PCDH10 PCDHB15 PCDHB10 PCDHB9 PCDHB4 PCDHGB4 DCHS1 DSG4	7.31e-07	114	213	10	2.60.40.60
Domain	CA	DCHS2 CDHR2 PCDH10 PCDHB15 PCDHB10 PCDHB9 PCDHB4 PCDHGB4 DCHS1 DSG4	7.92e-07	115	213	10	SM00112
Domain	Cadherin-like	DCHS2 CDHR2 PCDH10 PCDHB15 PCDHB10 PCDHB9 PCDHB4 PCDHGB4 DCHS1 DSG4	8.58e-07	116	213	10	IPR015919
Domain	Cadherin	DCHS2 CDHR2 PCDH10 PCDHB15 PCDHB10 PCDHB9 PCDHB4 PCDHGB4 DCHS1 DSG4	1.01e-06	118	213	10	IPR002126
Domain	Cadherin_C	PCDH10 PCDHB15 PCDHB10 PCDHB9 PCDHB4 PCDHGB4	7.64e-06	42	213	6	IPR032455
Domain	Cadherin_C_2	PCDH10 PCDHB15 PCDHB10 PCDHB9 PCDHB4 PCDHGB4	7.64e-06	42	213	6	PF16492
Domain	-	EPPK1 PLEC MACF1	2.85e-05	6	213	3	3.90.1290.10
Domain	Plectin	EPPK1 PLEC MACF1	4.95e-05	7	213	3	PF00681
Domain	Plectin_repeat	EPPK1 PLEC MACF1	4.95e-05	7	213	3	IPR001101
Domain	PLEC	EPPK1 PLEC MACF1	4.95e-05	7	213	3	SM00250
Domain	Cadherin_2	PCDH10 PCDHB15 PCDHB10 PCDHB9 PCDHB4 PCDHGB4	9.67e-05	65	213	6	PF08266
Domain	Cadherin_N	PCDH10 PCDHB15 PCDHB10 PCDHB9 PCDHB4 PCDHGB4	9.67e-05	65	213	6	IPR013164
Domain	-	PKLR PKM	1.29e-04	2	213	2	3.40.1380.20
Domain	PYRUVATE_KINASE	PKLR PKM	1.29e-04	2	213	2	PS00110
Domain	Pyrv_Knase_insert_dom	PKLR PKM	1.29e-04	2	213	2	IPR015806
Domain	Flot	FLOT2 FLOT1	1.29e-04	2	213	2	PF15975
Domain	PK	PKLR PKM	1.29e-04	2	213	2	PF00224
Domain	PK_C	PKLR PKM	1.29e-04	2	213	2	PF02887
Domain	-	PKLR PKM	1.29e-04	2	213	2	2.40.33.10
Domain	Flotillin_C	FLOT2 FLOT1	1.29e-04	2	213	2	IPR031905
Domain	Flotillin_fam	FLOT2 FLOT1	1.29e-04	2	213	2	IPR027705
Domain	Pyrv_Knase_AS	PKLR PKM	1.29e-04	2	213	2	IPR018209
Domain	Pyrv_Knase_brl	PKLR PKM	1.29e-04	2	213	2	IPR015793
Domain	Pyrv_Knase_a/b	PKLR PKM	1.29e-04	2	213	2	IPR015794
Domain	Pyrv_Knase_C	PKLR PKM	1.29e-04	2	213	2	IPR015795
Domain	Pyr_Knase	PKLR PKM	3.85e-04	3	213	2	IPR001697
Domain	Pyrv/PenolPyrv_Kinase-like_dom	PKLR PKM	3.85e-04	3	213	2	IPR015813
Domain	-	PKLR PKM	3.85e-04	3	213	2	3.20.20.60
Domain	-	RASIP1 FHAD1 CEP170B KIF1C	7.28e-04	36	213	4	2.60.200.20
Domain	FHA_dom	RASIP1 FHAD1 CEP170B KIF1C	7.28e-04	36	213	4	IPR000253
Domain	Ank_2	ACAP1 ANKRD63 ASB10 FEM1A ANKRD35 KANK3 ANKEF1 ANKRD24 SOWAHB	8.32e-04	215	213	9	PF12796
Domain	VWF_A	VWA5B2 HMCN2 COL7A1 ITGA10 CACNA2D4 SEC24C	9.52e-04	99	213	6	IPR002035
Domain	PIPLC_X_DOMAIN	ACAP1 PLCD1 PLCD3	1.24e-03	19	213	3	PS50007
Domain	PLipase_C_PInositol-sp_X_dom	ACAP1 PLCD1 PLCD3	1.24e-03	19	213	3	IPR000909
Domain	Pyrv_Knase-like_insert_dom	PKLR PKM	1.27e-03	5	213	2	IPR011037
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	VWA5B2 HIP1 LRWD1 EPPK1 SPEG INPPL1 NAGLU PEX6 C15orf39 LAMC3 MAPK8IP3 TAOK2 PPP1R26 TDRD3 SH3TC1 PTPRS MFN2 CACNA1H PLEC CHPF FEM1A RASAL1 PRRC2B NCK2 HSPG2 RHBDF1 KMT5C BAHD1 ANO8 PLCD3 SLC12A4 KANK3 HELZ2 TNFAIP2 IL4R CEP170B SOWAHB AHNAK2 RAB11FIP3	4.03e-18	1105	223	39	35748872
Pubmed	MBD3L1 and MBD3L2, two new proteins homologous to the methyl-CpG-binding proteins MBD2 and MBD3: characterization of MBD3L1 as a testis-specific transcriptional repressor.	MBD3L2 MBD3L5 MBD3L3 MBD3L4 MBD3L2B	6.18e-11	6	223	5	12504854
Pubmed	Haploid male germ cell- and oocyte-specific Mbd3l1 and Mbd3l2 genes are dispensable for early development, fertility, and zygotic DNA demethylation in the mouse.	MBD3L2 MBD3L5 MBD3L3 MBD3L4 MBD3L2B	6.18e-11	6	223	5	18942147
Pubmed	MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.	MBD3L2 MBD3L5 MBD3L3 MBD3L4 MBD3L2B	2.95e-08	15	223	5	15701600
Pubmed	Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer.	EPPK1 MAOA MCM7 HNRNPU FARSA CGN PKM FLOT2 SLC25A5 MYH14 FLOT1 TEDC1	1.62e-07	264	223	12	32814769
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SMC1A PPP1R26 RFTN1 CGN RNF169 ARHGAP23 SYNM VARS2 ANO8 PLCD3 HELZ2 MACF1 ANKRD24 DOP1A KIF1C	8.16e-07	493	223	15	15368895
Pubmed	The collagen type XVIII endostatin domain is co-localized with perlecan in basement membranes in vivo.	FBLN2 HSPG2 COL18A1	1.04e-06	4	223	3	12588956
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	ATXN2L WDR33 INPPL1 C15orf39 MCM7 TDRD3 FARSA SUPT5H NXF1 PRRC2B NCK2 UBA2 UNK MACF1 CEP170B TEDC1	1.50e-06	588	223	16	38580884
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ATXN2L HNRNPU MAPK8IP3 FARSA PTPRS AJM1 PKM SLC17A7 PLEC ALDH1B1 RASAL1 PRRC2B NCK2 FLOT2 NRDC ARHGAP23 SLC25A5 TPGS1 GJC2 SHROOM2 SEC24C MYH14 SLC4A10 MACF1 FLOT1 CEP170B	1.93e-06	1431	223	26	37142655
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ATXN2L LRWD1 SMC1A MAPK8IP3 MED24 PLEC RNF169 PHRF1 UBA2 NSMCE3 TERF2 AKT1S1 SEC24C HELZ2 UNK PROSER2 ZC3HAV1 RAVER1	3.02e-06	774	223	18	15302935
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	MAOA HNRNPU MAPK8IP3 SH3TC1 PTPRS CACNA1H MLPH NCK2 CACNA1C UBR2 UVSSA TMEM63C TPGS1 SHROOM2 ANO8 COL18A1 MYH14 ASMTL RBM5 MACF1 ZFHX3 ANKRD24 CEP170B DOP1A ZC3HAV1 RAVER1	3.95e-06	1489	223	26	28611215
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	HIP1 LRWD1 AUP1 TAOK2 MED24 RFTN1 TDRD3 FARSA PIK3C2A DNAJC9 NXF1 RNF169 RHBDF1 PHRF1 APLP2 TERF2 PLCD3 COL18A1 HELZ2 RBM5 UNK MACF1 AATF ZFHX3 CEP170B ZC3HAV1	4.35e-06	1497	223	26	31527615
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDH10 PCDHB15 PCDHB10 PCDHB9 PCDHB4 PCDHGB4	5.10e-06	68	223	6	11230163
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	ATXN2L EPPK1 WDR33 SMC1A HNRNPU TDRD3 FARSA SUPT5H NXF1 PRRC2B HELZ2 RBM5 UNK MACF1 AATF KIF1C ZC3HAV1 RAVER1	5.36e-06	807	223	18	22681889
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	ATXN2L WDR33 SMC1A INPPL1 MCM7 HNRNPU FARSA PIK3C2A CGN PKM ALDH1B1 MVP ACBD3 ANKRD35 UBR2 FLOT2 SLC25A5 TERF2 SEC24C MYH14 FLOT1 ZC3HAV1 RAVER1	6.16e-06	1247	223	23	27684187
Pubmed	Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways.	ATXN2L EPPK1 WDR33 HNRNPU PKM PLEC HELZ2 ZC3HAV1	6.69e-06	152	223	8	16009940
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDH10 PCDHB15 PCDHB10 PCDHB9 PCDHB4 PCDHGB4	7.13e-06	72	223	6	10380929
Pubmed	The human and murine protocadherin-beta one-exon gene families show high evolutionary conservation, despite the difference in gene number.	PCDHB15 PCDHB10 PCDHB9 PCDHB4	7.35e-06	20	223	4	11322959
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDH10 PCDHB15 PCDHB10 PCDHB9 PCDHB4 PCDHGB4	8.37e-06	74	223	6	10817752
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	ATXN2L WDR33 MRPL43 F2 TAOK2 FARSA PIK3C2A CGN DNAJC9 PKM PLEC NXF1 PRRC2B SLC25A5 VARS2 CUTC COL18A1 SEC24C MYH14 HELZ2 RBM5 AATF RNASEH1 FLOT1	9.14e-06	1371	223	24	36244648
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDH10 PCDHB15 PCDHB10 PCDHB9 PCDHB4 PCDHGB4	1.05e-05	77	223	6	10835267
Pubmed	Transcriptome-based systematic identification of extracellular matrix proteins.	LAMC3 FBLN2 HSPG2 COL7A1 EMILIN1 COL18A1	1.22e-05	79	223	6	18757743
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDH10 PCDHB15 PCDHB10 PCDHB9 PCDHB4 PCDHGB4	1.31e-05	80	223	6	10716726
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	ATXN2L ACAP1 EPPK1 SMC1A MCM7 HNRNPU DNAJC9 PKM PLEC MVP NXF1 FLOT2 SLC25A5 PLCD3 MYH14 FIZ1 AATF FLOT1 ZC3HAV1	1.34e-05	949	223	19	36574265
Pubmed	Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6.	ATXN2L INPPL1 MRPL43 MCM7 HNRNPU SUPT5H PKM PLEC ALDH1B1 HSPG2 FLOT2 SLC25A5 SEC24C MACF1 FLOT1 RAVER1	1.52e-05	707	223	16	19738201
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	ATXN2L AUP1 INPPL1 PGGT1B MED24 SLC12A9 DNAJC9 MFN2 BRD1 NXF1 RAD54L GJC2 APLP2 VARS2 VSIG10 BAHD1 CNNM3 NBAS C1orf115 SLC12A4 RBM5 SOWAHB RAB11FIP3	1.66e-05	1327	223	23	32694731
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	ATXN2L MAPK8IP3 PIK3C2A AJM1 PLEC ADGRL3 CACNA1C SLC4A10 MACF1 CEP170B JPH3	1.68e-05	347	223	11	17114649
Pubmed	SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers.	HNRNPU TDRD3 PKM PLEC HSPG2 SLC25A5 EMILIN1 COL18A1	1.72e-05	173	223	8	23979707
Pubmed	Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance.	FBLN2 PKM HSPG2 EMILIN1 COL18A1	1.74e-05	50	223	5	23658023
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	ATXN2L APC2 MAPK8IP3 FBLN2 PKM MVP OPLAH ANKRD35 CACNA1C SHARPIN RBM5 AATF ANKRD24 KIF1C	1.77e-05	560	223	14	21653829
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	F2 FBLN2 HMCN2 HSPG2 COL7A1 EMILIN1 COL18A1 CST3	1.87e-05	175	223	8	28071719
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	SPEG MAPK8IP3 AJM1 PRRC2B GJC2 SLC4A10 MACF1 CEP170B JPH3	2.01e-05	231	223	9	16452087
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	MAOA SPEG NAGLU MCM7 HNRNPU FBLN2 FIBIN AJM1 PKM PLEC ACBD3 POMT2 ANKRD35 HSPG2 LURAP1 ARHGAP23 SLC25A5 MXRA8 VARS2 ARSB SEC24C CST3 ZC3HAV1 RAVER1	2.30e-05	1451	223	24	30550785
Pubmed	Defining the membrane proteome of NK cells.	ATXN2L ACAP1 GHDC AUP1 DHRS13 MCM7 HNRNPU FARSA PIK3C2A MVP ACBD3 FLOT2 SLC25A5 PHRF1 APLP2 OGFOD3 CNNM3 NBAS MYH14 HELZ2 FLOT1	2.31e-05	1168	223	21	19946888
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ATXN2L EPPK1 SUPT5H CGN PLEC MVP NXF1 PRRC2B PHRF1 SEC24C MYH14 HELZ2 MACF1 AATF ZC3HAV1	2.37e-05	653	223	15	22586326
Pubmed	Laser capture microdissection and cDNA array analysis for identification of mouse KIAA/FLJ genes differentially expressed in the embryonic dorsal spinal cord.	CACNA1H PHRF1 SEC24C MACF1	2.57e-05	27	223	4	19026994
Pubmed	CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11(p110).	SMC1A MCM7 HNRNPU FARSA PKM	2.78e-05	55	223	5	23178491
Pubmed	Mechanism of glycyrrhizic acid inhibition of Kaposi's sarcoma-associated herpesvirus: disruption of CTCF-cohesin-mediated RNA polymerase II pausing and sister chromatid cohesion.	SMC1A MCM7 SUPT5H	3.02e-05	10	223	3	21880767
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	MKRN3 DCHS2 PDE7A SMC1A APC2 MAPK8IP3 SUPT5H PKM PLEC CHPF MVP ACBD3 LURAP1 SYNM FBXW4 SHROOM2 MYH14 SHARPIN MACF1 ANKRD24 FLOT1 JPH3	3.08e-05	1285	223	22	35914814
Pubmed	Functional proteomics mapping of a human signaling pathway.	AUP1 PEX6 PPP1R26 SUPT5H PLEC BRD1 CHPF ACBD3 HSPG2 MRI1 APLP2 PLCD3 SLC12A4 MACF1	3.19e-05	591	223	14	15231748
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	PCDHB15 PCDHB10 PCDHB9 PCDHB4 PCDHGB4	3.31e-05	57	223	5	32633719
Pubmed	CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.	PCDHB15 PCDHB10 PCDHB9 PCDHB4 PCDHGB4	3.60e-05	58	223	5	30377227
Pubmed	Flotillin-Dependent Membrane Microdomains Are Required for Functional Phagolysosomes against Fungal Infections.	FLOT2 FLOT1	4.09e-05	2	223	2	32814035
Pubmed	Structure and function of human erythrocyte pyruvate kinase. Molecular basis of nonspherocytic hemolytic anemia.	PKLR PKM	4.09e-05	2	223	2	11960989
Pubmed	Pyruvate Kinase M2 Activates mTORC1 by Phosphorylating AKT1S1.	PKM AKT1S1	4.09e-05	2	223	2	26876154
Pubmed	Expression and function of phospholipase C in breast carcinoma.	PLCD1 PLCD3	4.09e-05	2	223	2	19344632
Pubmed	Plakins in development and disease.	EPPK1 PLEC	4.09e-05	2	223	2	17499243
Pubmed	Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis.	PKLR PKM	4.09e-05	2	223	2	15996096
Pubmed	Stomatin, flotillin-1, and flotillin-2 are major integral proteins of erythrocyte lipid rafts.	FLOT2 FLOT1	4.09e-05	2	223	2	11159550
Pubmed	Hetero-oligomerization of reggie-1/flotillin-2 and reggie-2/flotillin-1 is required for their endocytosis.	FLOT2 FLOT1	4.09e-05	2	223	2	19318123
Pubmed	Infection by Anaplasma phagocytophilum Requires Recruitment of Low-Density Lipoprotein Cholesterol by Flotillins.	FLOT2 FLOT1	4.09e-05	2	223	2	30914515
Pubmed	PLCD3, a flotillin2-interacting protein, is involved in proliferation, migration and invasion of nasopharyngeal carcinoma cells.	FLOT2 PLCD3	4.09e-05	2	223	2	29115528
Pubmed	Expression of flotillins in the human placenta: potential implications for placental transcytosis.	FLOT2 FLOT1	4.09e-05	2	223	2	23064789
Pubmed	Xanthine oxidoreductase is central to the evolution and function of the innate immune system.	FLOT2 FLOT1	4.09e-05	2	223	2	12967676
Pubmed	Coassembly of flotillins induces formation of membrane microdomains, membrane curvature, and vesicle budding.	FLOT2 FLOT1	4.09e-05	2	223	2	17600709
Pubmed	Up-regulation of the proapoptotic caspase 2 splicing isoform by a candidate tumor suppressor, RBM5.	CASP2 RBM5	4.09e-05	2	223	2	18840686
Pubmed	CACNA1H downregulation induces skeletal muscle atrophy involving endoplasmic reticulum stress activation and autophagy flux blockade.	CACNA1H CACNA1C	4.09e-05	2	223	2	32332705
Pubmed	Evidence of a dosage effect and a physiological endplate acetylcholinesterase deficiency in the first mouse models mimicking Schwartz-Jampel syndrome neuromyotonia.	ACHE HSPG2	4.09e-05	2	223	2	18647752
Pubmed	Evidence for chemokine-mediated coalescence of preformed flotillin hetero-oligomers in human T-cells.	FLOT2 FLOT1	4.09e-05	2	223	2	23012365
Pubmed	Flotillin 2 is distinct from epidermal surface antigen (ESA) and is associated with filopodia formation.	FLOT2 FLOT1	4.09e-05	2	223	2	10462713
Pubmed	Phospholipase C isoforms delta 1 and delta 3 from human fibroblasts. High-yield expression in Escherichia coli, simple purification, and properties.	PLCD1 PLCD3	4.09e-05	2	223	2	9056492
Pubmed	KIF1C and new Huntingtin-interacting protein 1 binding proteins regulate rheumatoid arthritis fibroblast-like synoviocytes' phenotypes.	HIP1 KIF1C	4.09e-05	2	223	2	38726004
Pubmed	Physiological functions of phospholipase Cδ1 and phospholipase Cδ3.	PLCD1 PLCD3	4.09e-05	2	223	2	23948486
Pubmed	Flotillin microdomains interact with the cortical cytoskeleton to control uropod formation and neutrophil recruitment.	FLOT2 FLOT1	4.09e-05	2	223	2	21059848
Pubmed	Chronic hypoxia selectively enhances L- and T-type voltage-dependent Ca2+ channel activity in pulmonary artery by upregulating Cav1.2 and Cav3.2.	CACNA1H CACNA1C	4.09e-05	2	223	2	23686856
Pubmed	Alopecia in a viable phospholipase C delta 1 and phospholipase C delta 3 double mutant.	PLCD1 PLCD3	4.09e-05	2	223	2	22723964
Pubmed	Ca2+ influx through T- and L-type Ca2+ channels have different effects on myocyte contractility and induce unique cardiac phenotypes.	CACNA1H CACNA1C	4.09e-05	2	223	2	18832749
Pubmed	Flotillins in the intercalated disc are potential modulators of cardiac excitability.	FLOT2 FLOT1	4.09e-05	2	223	2	30452906
Pubmed	Deletion of the basement membrane heparan sulfate proteoglycan type XVIII collagen causes hypertriglyceridemia in mice and humans.	HSPG2 COL18A1	4.09e-05	2	223	2	21085708
Pubmed	Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney.	HSPG2 COL18A1	4.09e-05	2	223	2	12514129
Pubmed	Association of ORCA/LRWD1 with repressive histone methyl transferases mediates heterochromatin organization.	LRWD1 KMT5C	4.09e-05	2	223	2	26765314
Pubmed	Interactions of silica nanoparticles with lung epithelial cells and the association to flotillins.	FLOT2 FLOT1	4.09e-05	2	223	2	22669515
Pubmed	Flotillin-1: gene structure: cDNA cloning from human lung and the identification of alternative polyadenylation signals.	FLOT2 FLOT1	4.09e-05	2	223	2	11167132
Pubmed	Reggies/flotillins regulate retinal axon regeneration in the zebrafish optic nerve and differentiation of hippocampal and N2a neurons.	FLOT2 FLOT1	4.09e-05	2	223	2	19458231
Pubmed	Flotillin-mediated endocytic events dictate cell type-specific responses to semaphorin 3A.	FLOT2 FLOT1	4.09e-05	2	223	2	21068336
Pubmed	Flotillin-2 expression in the human gut: from a cell model to human tissue in health and inflammatory bowel diseases.	FLOT2 FLOT1	4.09e-05	2	223	2	23983584
Pubmed	Insufficient radiofrequency ablation promotes the metastasis of residual hepatocellular carcinoma cells via upregulating flotillin proteins.	FLOT2 FLOT1	4.09e-05	2	223	2	30820716
Pubmed	Flotillins are involved in the polarization of primitive and mature hematopoietic cells.	FLOT2 FLOT1	4.09e-05	2	223	2	20027317
Pubmed	Analysis of close associations of uropod-associated proteins in human T-cells using the proximity ligation assay.	FLOT2 FLOT1	4.09e-05	2	223	2	24167781
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	LRWD1 EPPK1 AUP1 WDR33 MCM7 HNRNPU FARSA DNAJC9 PKM NXF1 MRI1 SLC25A5 UBA2 NBAS SEC24C	5.56e-05	704	223	15	29955894
Pubmed	Therapeutic targeting of the USP2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression.	ATXN2L MRPL43 MCM7 TDRD3 DNAJC9 NXF1 PRRC2B COL18A1 LPL AATF ZC3HAV1	6.53e-05	403	223	11	35253629
Pubmed	Protocadherins.	PCDHB10 PCDHB9 PCDHB4	7.09e-05	13	223	3	12231349
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	ATXN2L LRWD1 TDRD3 PIK3C2A PLEC NXF1 PRRC2B NSMCE3 MYH14 UNK MACF1 AATF AHNAK2 ZC3HAV1 RAVER1	7.60e-05	724	223	15	36232890
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	NOL4 WDR33 SMC1A HNRNPU FARSA SUPT5H PKM PLEC MVP NXF1 FLOT2 SLC25A5 APLP2 SEC24C HELZ2 MKX RBM5 MACF1 FLOT1	7.83e-05	1082	223	19	38697112
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	EPPK1 WDR33 SMC1A INPPL1 MRPL43 MCM7 FARSA CGN DNAJC9 PLEC FLOT2 RNF169 ARHGAP23 ARID3B RBM5 FLOT1 RAVER1	9.73e-05	916	223	17	32203420
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	MAOA AUP1 WDR33 MRPL43 PEX6 TDRD3 PIK3C2A DNAJC9 MFN2 ALDH1B1 ACBD3 PRRC2B FLOT2 SLC25A5 SYNM TPGS1 VARS2 NBAS AATF FLOT1 AHNAK2 ZC3HAV1 RAVER1	1.03e-04	1496	223	23	32877691
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	LRWD1 EPPK1 SMC1A MCM7 HNRNPU SUPT5H CGN PKM PLEC NXF1 FLOT2 SLC25A5 CNNM3 SEC24C MYH14 MACF1 AATF FLOT1	1.20e-04	1024	223	18	24711643
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	HNRNPU CGN PKM PLEC MVP FLOT2 SYNM UBA2 MACF1 AHNAK2	1.22e-04	360	223	10	33111431
Pubmed	Physiological functions of phospholipase C delta-type.	PLCD1 PLCD3	1.22e-04	3	223	2	18177742
Pubmed	Dynamic reorganization of flotillins in chemokine-stimulated human T-lymphocytes.	FLOT2 FLOT1	1.22e-04	3	223	2	21696602
Pubmed	Arginase-flotillin interaction brings arginase to red blood cell membrane.	FLOT2 FLOT1	1.22e-04	3	223	2	17113085
Pubmed	Association study between polymorphisms in the CACNA1A, CACNA1C, and CACNA1H genes and drug-resistant epilepsy in the Chinese Han population.	CACNA1H CACNA1C	1.22e-04	3	223	2	26216687
Pubmed	PKM2 coordinates glycolysis with mitochondrial fusion and oxidative phosphorylation.	PKM MFN2	1.22e-04	3	223	2	30887444
Pubmed	The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans.	FBLN2 HSPG2	1.22e-04	3	223	2	9431988
Pubmed	Role of dynamin and clathrin in the cellular trafficking of flotillins.	FLOT2 FLOT1	1.22e-04	3	223	2	24809731
Pubmed	Flotillins play an essential role in Niemann-Pick C1-like 1-mediated cholesterol uptake.	FLOT2 FLOT1	1.22e-04	3	223	2	21187433
Pubmed	Dynamic and functional assembly of the AAA peroxins, Pex1p and Pex6p, and their membrane receptor Pex26p.	PEX6 PEX26	1.22e-04	3	223	2	16854980
Pubmed	Expression of voltage sensitive calcium channel (VSCC) L-type Cav1.2 (alpha1C) and T-type Cav3.2 (alpha1H) subunits during mouse bone development.	CACNA1H CACNA1C	1.22e-04	3	223	2	16059921
Pubmed	T-type, but not L-type, voltage-gated calcium channels are dispensable for lymphatic pacemaking and spontaneous contractions.	CACNA1H CACNA1C	1.22e-04	3	223	2	31919478
Pubmed	GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism.	PKM UBA2	1.22e-04	3	223	2	36116159
Interaction	TOP3B interactions	VWA5B2 HIP1 LRWD1 EPPK1 SPEG SMC1A INPPL1 NAGLU PEX6 C15orf39 LAMC3 HNRNPU MAPK8IP3 TAOK2 PPP1R26 TDRD3 SH3TC1 PTPRS MFN2 CACNA1H PLEC CHPF FEM1A RASAL1 PRRC2B NCK2 HSPG2 RHBDF1 KMT5C BAHD1 ANO8 PLCD3 SLC12A4 KANK3 HELZ2 UNK TNFAIP2 IL4R CEP170B SOWAHB AHNAK2 ZC3HAV1 RAB11FIP3	1.29e-09	1470	216	43	int:TOP3B
Cytoband	Ensembl 112 genes in cytogenetic band chr19p13	MBD3L2 APC2 FARSA PTPRS FEM1A MBD3L5 MRI1 CAPS TPGS1 MBD3L3 MBD3L4 JSRP1 ANO8 MBD3L2B ANGPTL6 CCDC194 KANK3 ANKRD24 RAVER1	1.64e-08	797	223	19	chr19p13
Cytoband	19p13.2	MBD3L2 FARSA MBD3L5 MRI1 MBD3L3 MBD3L4 MBD3L2B ANGPTL6 KANK3 RAVER1	2.12e-07	229	223	10	19p13.2
Cytoband	19p13.3	APC2 PTPRS FEM1A CAPS TPGS1 JSRP1 ANKRD24	1.72e-04	237	223	7	19p13.3
Cytoband	5q31	PCDHB15 PCDHB10 PCDHB9 PCDHB4 PCDHGB4	2.57e-04	115	223	5	5q31
GeneFamily	EF-hand domain containing\|Plakins	EPPK1 PLEC MACF1	2.64e-05	8	143	3	939
GeneFamily	Flotillins	FLOT2 FLOT1	6.21e-05	2	143	2	1114
GeneFamily	Ankyrin repeat domain containing	ACAP1 ANKRD63 ASB10 FEM1A ANKRD35 KANK3 ANKEF1 ANKRD24 SOWAHB	1.34e-04	242	143	9	403
GeneFamily	Clustered protocadherins	PCDHB15 PCDHB10 PCDHB9 PCDHB4 PCDHGB4	1.51e-04	64	143	5	20
GeneFamily	Cadherin related	DCHS2 CDHR2 DCHS1	3.04e-04	17	143	3	24
GeneFamily	Calcium voltage-gated channel subunits	CACNA1H CACNA1C CACNA2D4	1.10e-03	26	143	3	253
GeneFamily	G protein-coupled receptors, Class C orphans	GPR179 GPRC5D	1.27e-03	7	143	2	285
GeneFamily	Fibulins	FBLN2 HMCN2	1.69e-03	8	143	2	556
GeneFamily	Zinc fingers CCCH-type	ZC3H12D UNK ZC3HAV1	2.63e-03	35	143	3	73
ToppCell	P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MXD3 DCHS2 DHRS13 MCM7 PPP1R26 DNAJC9 RAD54L ITGA10 SHROOM2 SAMD10	1.74e-08	172	223	10	7c238a7375341d4647ba7274d93fddfb6fae7ce4
ToppCell	Pericytes-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	SYNPO2 LAMC3 FIBIN HRC CACNA1H ADGRL3 CACNA1C SYNM PCDHB10 PCDHB4	2.05e-08	175	223	10	ddf721023a7afc8085c5de17aa254a6575444c0f
ToppCell	droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPEG ASB10 HRC SLC17A7 MFN2 TRIM72 CACNA1C ERICH3 FSD2 MYH14	4.93e-08	192	223	10	f6a4e348406a852ace9fb21db8fbdff539217645
ToppCell	droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPEG ASB10 HRC SLC17A7 MFN2 TRIM72 CACNA1C ERICH3 FSD2 MYH14	4.93e-08	192	223	10	1a0c25106ae08eac912a4edd5fc1a3ee776f69c2
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26\|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.	FBLN2 PLEC PDZD4 ARHGAP23 ITGA10 C1orf115 LPL CST3 ANKRD24 JPH3	7.23e-08	200	223	10	5c7263c862093ad9dbc81d06b16b6f74e8a6b634
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26\|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type.	KCNE5 FBLN2 PLEC PDZD4 ARHGAP23 ITGA10 C1orf115 LPL CST3 ANKRD24	7.23e-08	200	223	10	61d7dd0a78942b069c3f5e75044368dc00e6e8e6
ToppCell	Adult-Mesenchymal-pericyte_cell-D231\|Adult / Lineage, Cell type, age group and donor	SPEG C15orf39 LAMC3 RASIP1 CACNA1H ADGRL3 CACNA1C SYNM COL18A1	2.24e-07	172	223	9	858cee96c1c06160863b4adcd7023c0d678bd50f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 KCTD11 SLC17A7 ALDH1B1 FAM181B PDZD4 SYNM PCDHB10 EMILIN1	2.35e-07	173	223	9	ecbf7167d4bec685e3460d826318544946f5f5c2
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 KCTD11 SLC17A7 ALDH1B1 FAM181B PDZD4 SYNM PCDHB10 EMILIN1	2.35e-07	173	223	9	b8dc978c52de64afba21ff6cb32e79f07167448e
ToppCell	COVID-19-Heart-VSMC\|Heart / Disease (COVID-19 only), tissue and cell type	HIP1 EPPK1 SPEG CACNA1H CACNA1C UBA2 COL18A1 ZFHX3 IL4R	3.14e-07	179	223	9	a69ad6912b5c10bb9f9d800f724c792341e9bab1
ToppCell	Pericytes-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	SYNPO2 SPEG HRC CACNA1H ADGRL3 CACNA1C SYNM COL18A1 ZFHX3	3.61e-07	182	223	9	46c213597445b1f4f09dc367f27702d24b201daf
ToppCell	tumor_Lung-Fibroblasts-Pericytes\|Fibroblasts / Location, Cell class and cell subclass	LAMC3 HRC CACNA1H NCK2 SYNM UBA2 SHROOM2 COL18A1 LPL	4.96e-07	189	223	9	9c407b17d7945e81e1ae6c18452f5d20fb09d563
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 SPEG ASB10 HRC ADGRL3 SYNM UBA2 EMILIN1 ZFHX3	7.02e-07	197	223	9	aafe279b14cdcb786bc45524bc3c26261128ee48
ToppCell	356C-Fibroblasts-Fibroblast-K_(Pericytes)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	SYNPO2 SPEG CACNA1H ALDH1B1 ADGRL3 SYNM ITGA10 KANK3 MKX	7.02e-07	197	223	9	0f9836554ace3f9d155ebafdd719aa26466ca44e
ToppCell	356C-Fibroblasts-Fibroblast-K_(Pericytes)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	SYNPO2 SPEG CACNA1H ALDH1B1 ADGRL3 SYNM ITGA10 KANK3 MKX	7.02e-07	197	223	9	71367bebc23d0e81f60f780d6b0ab3a1783ac014
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 SPEG ASB10 HRC ADGRL3 SYNM UBA2 EMILIN1 ZFHX3	7.02e-07	197	223	9	fb14da600f563273059a4683a5079af81aca0886
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 SPEG ASB10 HRC ADGRL3 SYNM EMILIN1 MKX ZFHX3	7.32e-07	198	223	9	77288df94286382170a266474ab85960519e8449
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 SPEG ASB10 HRC ADGRL3 SYNM EMILIN1 MKX ZFHX3	7.32e-07	198	223	9	2ee195f20a4f91fa1dcad9eaf96d6086e3b0fb4a
ToppCell	Bronchus_Control_(B.)-Stromal-TX-Smooth_muscle-2\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	SYNPO2 SPEG HRC CACNA1H PCDH10 CACNA1C SYNM EMILIN1 KANK3	7.64e-07	199	223	9	2c5ad62919c64ea0242e0984bb9932d2d975f4e3
ToppCell	RV-13._Vascular_Smooth_Muscle\|RV / Chamber and Cluster_Paper	HIP1 EPPK1 HMCN2 CACNA1H ADGRL3 CACNA1C COL18A1 ZFHX3	1.57e-06	161	223	8	47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	MXD3 ACAP1 TDRD3 SUPT5H CCHCR1 MXRA8 CEP170B RAB11FIP3	2.26e-06	169	223	8	665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	MXD3 ACAP1 TDRD3 SUPT5H CCHCR1 MXRA8 CEP170B RAB11FIP3	2.26e-06	169	223	8	6614c9851537e4c21b1e45ff0cc3bad07ef9d034
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSTD1 PRRC2B HSPG2 NBAS COL18A1 SLC4A10 KCTD18 RAB11FIP3	2.69e-06	173	223	8	8bffd512a4e561e23cc04478e2ca6fd5d3771fe4
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSTD1 PRRC2B HSPG2 NBAS COL18A1 SLC4A10 KCTD18 RAB11FIP3	2.69e-06	173	223	8	3e3c61468e703330788a10d850ef41a85680f86d
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LAMC3 RFTN1 HRC CACNA1H NCK2 CACNA1C SYNM SHROOM2	3.76e-06	181	223	8	451b87ac95154bb80018b8dd245b4a6389d81411
ToppCell	Basal\|World / shred by cell class for mouse tongue	HIP1 PTPRS KCNH1 PLEC COL7A1 COL18A1 SLC12A4 ZFHX3	4.08e-06	183	223	8	c6729a207526ff4aa48176207b9353176f631fea
ToppCell	Pericytes-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	SYNPO2 SPEG ADGRL3 CACNA1C SYNM MXRA8 COL18A1 DCHS1	4.25e-06	184	223	8	cd10d351d91a81dd6dc806cb4e0c8d7861c98e0b
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4\|TCGA-Thryoid / Sample_Type by Project: Shred V9	DCHS2 RHBDF1 C2CD4A PLCD3 MYH14 CEP170B SOWAHB AHNAK2	4.25e-06	184	223	8	d9659d1e4465fec68f48a22edef443f354f6c7cf
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LAMC3 RFTN1 CACNA1H CACNA1C SYNM COL18A1 KANK3 LPL	4.42e-06	185	223	8	a7dba7db79275884b2a93d8a16f2e0c739e71370
ToppCell	facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ASB10 HRC SLC17A7 CACNA1H ALDH1B1 TRIM72 FSD2 MYH14	4.60e-06	186	223	8	337f768cc43db2db96ba6495b076006b1a5b0331
ToppCell	facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ASB10 HRC SLC17A7 CACNA1H ALDH1B1 TRIM72 FSD2 MYH14	4.60e-06	186	223	8	e378c82ef6d6cb24751515aa499a01372b3e7ccf
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LAMC3 RFTN1 CACNA1H NCK2 CACNA1C SYNM COL18A1 LPL	4.79e-06	187	223	8	a2bf958ea59c359a265bfa437d59315e1920cdd4
ToppCell	IPF-Stromal-SMC\|World / Disease state, Lineage and Cell class	SYNPO2 SPEG HRC CACNA1H ADGRL3 CACNA1C SYNM COL18A1	4.98e-06	188	223	8	b66264e8f8d536ed2beec31e6746c687718f239b
ToppCell	IPF-Stromal-SMC\|IPF / Disease state, Lineage and Cell class	SYNPO2 SPEG HRC CACNA1H ADGRL3 CACNA1C SYNM COL18A1	4.98e-06	188	223	8	e98b24c0de41285f01f7ac194ff0a1b59fd5c333
ToppCell	Mesenchymal-pericyte_cell\|World / Lineage, Cell type, age group and donor	LAMC3 RFTN1 CACNA1H NCK2 CACNA1C SYNM COL18A1 LPL	5.18e-06	189	223	8	d7ed96add29f219183c802895fbff519b627f635
ToppCell	droplet-Kidney-nan-21m-Epithelial-kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNPO2 SPEG ANKRD63 FIBIN HRC SYNM EMILIN1 ZFHX3	5.38e-06	190	223	8	1803b1e7c36285f9eaabc3c6e9a9752c5908db3d
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Stroma____kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNPO2 SPEG FIBIN HRC CACNA1H CACNA1C SYNM ZFHX3	5.59e-06	191	223	8	8597a8af294f24496c317d995f07eb5dcc25c13c
ToppCell	droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HRC SLC17A7 MFN2 CACNA1H ALDH1B1 TRIM72 FSD2 MYH14	5.81e-06	192	223	8	0bf99e029a06151092db1e8a0dcb45f4e688e771
ToppCell	droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HRC SLC17A7 MFN2 CACNA1H ALDH1B1 TRIM72 FSD2 MYH14	5.81e-06	192	223	8	d766221acfce30cbf2c60b3ae40f6744968b952c
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MKRN3 ACAP1 SELENOO CACNA1H SYNM FBXW4 MACF1 RAB11FIP3	6.27e-06	194	223	8	3211d89440a6f4a9b3d4cfb755890816944242ec
ToppCell	COVID-19-lung-Pericytes/_Smooth_Muscle\|lung / Disease (COVID-19 only), tissue and cell type	SYNPO2 SPEG LAMC3 CACNA1H ADGRL3 CACNA1C SYNM COL18A1	6.27e-06	194	223	8	5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3
ToppCell	IPF-Stromal-Pericyte\|Stromal / Disease state, Lineage and Cell class	HIP1 LAMC3 RFTN1 HRC CACNA1H NCK2 COL18A1 LPL	6.27e-06	194	223	8	3892b188f424ffb80f3c75a1b6709a21c1e1601d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FAM241A RASIP1 PIK3C2A HSPG2 ARHGAP23 ARSB KANK3 IL4R	6.51e-06	195	223	8	818bc18c5834238e5f733cac6fe928ed0788f57d
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SYNPO2 SPEG HRC CACNA1H ADGRL3 SYNM EMILIN1 COL18A1	6.76e-06	196	223	8	70b2e0b4ff4f1bc03fb72ace07a8a44f4b415922
ToppCell	Pericytes\|World / shred by cell class for parenchyma	SYNPO2 SPEG HRC CACNA1H ALDH1B1 ADGRL3 SYNM COL18A1	6.76e-06	196	223	8	8e7ecbe77d312a7fc6aadd8fd52c13dd1834cc7e
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SYNPO2 LAMC3 HRC CACNA1H MXRA8 ITGA10 EMILIN1 COL18A1	6.76e-06	196	223	8	7acd782a587b7d331517f60daa8b5c2177bedfc7
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SYNPO2 SPEG HRC CACNA1H ADGRL3 SYNM EMILIN1 COL18A1	6.76e-06	196	223	8	ac4c8571bd792538f8df7b9bdd90ef58405fd3b1
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SYNPO2 SPEG HMCN2 CACNA1H FAM181B ADGRL3 CACNA1C COL18A1	7.01e-06	197	223	8	cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c
ToppCell	Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SYNPO2 SPEG HRC CACNA1H ADGRL3 CACNA1C SYNM COL18A1	7.01e-06	197	223	8	3f078be0b0f5e16edfb6d517beb20ac6178767f0
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LAMC3 RFTN1 CACNA1H NCK2 CACNA1C SYNM UBA2 COL18A1	7.01e-06	197	223	8	41dd312f46a2b983c8d864adeb6970c0ca4a8048
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LAMC3 RFTN1 CACNA1H NCK2 CACNA1C SYNM UBA2 COL18A1	7.01e-06	197	223	8	f66945f9007d59d4208849c7fd727f8519713fbc
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SYNPO2 SPEG HMCN2 CACNA1H ADGRL3 CACNA1C SYNM MKX	7.01e-06	197	223	8	bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 SPEG HRC ADGRL3 SYNM UBA2 EMILIN1 ZFHX3	7.01e-06	197	223	8	8b3bf5b45e49bf1c60e4d2703b470bb890385f67
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SYNPO2 LAMC3 HRC CACNA1H MXRA8 ITGA10 EMILIN1 COL18A1	7.01e-06	197	223	8	983502a99e6d59bb36225b0246a9990604de1a01
ToppCell	Transplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle\|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X	SYNPO2 SPEG HRC CACNA1H ADGRL3 SYNM KANK3 ZFHX3	7.28e-06	198	223	8	89986c7756541df364df516329d10775ba0e78a4
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SYNPO2 SPEG HRC CACNA1H ADGRL3 CACNA1C SYNM COL18A1	7.28e-06	198	223	8	705118a5db366b43ffd3389c60e4cb392ad3f2e6
ToppCell	cellseq-Mesenchymal-Myocytic-Myocytic_2-VSMC\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SYNPO2 SPEG HRC CACNA1H ADGRL3 CACNA1C MXRA8 COL18A1	7.28e-06	198	223	8	e967c601101361fc1c48dab0e5b76dc68813276e
ToppCell	background-Hepatic_Stellate_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	SYNPO2 LAMC3 SGCZ FIBIN CACNA1C MXRA8 EMILIN1 ANGPTL6	7.28e-06	198	223	8	bd11b0e9e80449aab979a02c1023e0638c431c7c
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Trm_Tgd\|Lung / Manually curated celltypes from each tissue	SYNPO2 PDE7A DNAJC9 LURAP1 RHBDF1 GJC2 SAMD10	7.54e-06	142	223	7	c3db15bcb305ebdf5c9ca0b5c8ce63fab978590b
ToppCell	Tracheal-10x5prime-Stromal-Myofibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SYNPO2 SPEG HRC CACNA1H ADGRL3 CACNA1C SYNM COL18A1	7.55e-06	199	223	8	0a145172787f40d0fdaf21188d539ffaf7ece3e4
ToppCell	Skin-Mesangial\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	DCHS2 SYNPO2 SPEG CHST7 SYNM WNT1 EMILIN1 ANKRD24	7.55e-06	199	223	8	bcb78838a91cc7828680fb413fbacdb091c5fac0
ToppCell	Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SYNPO2 SPEG HRC CACNA1H ALDH1B1 ADGRL3 CACNA1C SYNM	7.55e-06	199	223	8	056a28c36cd58dc695a5ae6f29b62135d6aad819
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SYNPO2 SPEG HRC CACNA1H ADGRL3 CACNA1C SYNM COL18A1	7.55e-06	199	223	8	ad75e5e26c37a97331164d7f77235ebd9a933a44
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-2\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	SYNPO2 SPEG HRC CACNA1H ADGRL3 CACNA1C SYNM COL18A1	7.55e-06	199	223	8	706b7de777ff86eb22e538ccd5c2987ceb6be308
ToppCell	Tracheal-10x3prime_v2-Stromal-Myofibroblastic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SYNPO2 SPEG HRC CACNA1H ALDH1B1 ADGRL3 CACNA1C SYNM	7.55e-06	199	223	8	534dcfe8b65ad92bb8d749d1c7036ad4807e09cd
ToppCell	Parenchyma_COVID-19-Stromal-TX-Smooth_muscle-2\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	SYNPO2 SPEG HRC CACNA1H ADGRL3 SYNM COL18A1 ZFHX3	7.55e-06	199	223	8	c8bc05dece8b8a87d4a7a3e8112b924e15217de1
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SYNPO2 SPEG HRC CACNA1H ADGRL3 SYNM COL18A1 ZFHX3	7.55e-06	199	223	8	78b245d40c1e169ff2d26907b63d732e34529c5f
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	SYNPO2 SPEG HRC CACNA1H ADGRL3 SYNM COL18A1 ZFHX3	7.55e-06	199	223	8	8e1e95c3a4b856415af208be6ad977e575bac189
ToppCell	cellseq-Mesenchymal-Myocytic\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SYNPO2 LAMC3 HRC CACNA1H SYNM MXRA8 EMILIN1 COL18A1	7.55e-06	199	223	8	20e62a7029fa0d214244cdf2a481fc5d78290438
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-2\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	SYNPO2 SPEG HRC CACNA1H ADGRL3 CACNA1C SYNM COL18A1	7.55e-06	199	223	8	471738f2059e20407572d9c4cbd11812068333ea
ToppCell	Parenchymal-10x5prime-Stromal-Myofibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SYNPO2 SPEG HRC CACNA1H ADGRL3 CACNA1C MXRA8 COL18A1	7.55e-06	199	223	8	20f760d92c351a1dac4cc0a424c443ea03a179fe
ToppCell	metastatic_Brain-Fibroblasts\|metastatic_Brain / Location, Cell class and cell subclass	SYNPO2 LAMC3 FBLN2 FIBIN CACNA1C MXRA8 EMILIN1 COL18A1	7.55e-06	199	223	8	63eb2106bb6e2e33d020628583536c8d96662c84
ToppCell	Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SYNPO2 SPEG HRC CACNA1H ADGRL3 CACNA1C MXRA8 COL18A1	7.55e-06	199	223	8	7c272a1aa7f3e931ad5d20809719d85b3bce4cb0
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMC3 RASIP1 HRC HSPG2 ITGA10 COL18A1 C1orf115 KANK3	7.55e-06	199	223	8	1295f34a350bf48987e2fad411aaac3630efd3f1
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-2-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SYNPO2 SPEG HRC CACNA1H ADGRL3 CACNA1C SYNM COL18A1	7.55e-06	199	223	8	690a4f84b205532c4c9e5c19d5ae430d0655f421
ToppCell	Biopsy_Control_(H.)-Mesenchymal-Smooth_Muscle_cells\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	SYNPO2 LAMC3 HRC CACNA1H ADGRL3 CACNA1C MXRA8 COL18A1	7.55e-06	199	223	8	31c781a1787e5140fb3f611823cbab4d13d02dfa
ToppCell	Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LAMC3 HRC CACNA1H NCK2 CACNA1C SYNM MXRA8 COL18A1	7.83e-06	200	223	8	12326cc6f0af24bacba9493dc79e7c7347db2f41
ToppCell	Parenchymal-10x3prime_v2-Stromal-Pericyte\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	LAMC3 RFTN1 CACNA1H NCK2 SYNM MXRA8 COL18A1 LPL	7.83e-06	200	223	8	d70bad979299615fcba707ba21296020918705e6
ToppCell	proximal-mesenchymal-Airway_Smooth_Muscle-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SYNPO2 SPEG HRC CACNA1H ADGRL3 SYNM EMILIN1 COL18A1	7.83e-06	200	223	8	6fa339666c4032b29ac521e88f0e917a57013cde
ToppCell	Bronchial-10x5prime-Stromal-Pericyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LAMC3 HRC CACNA1H NCK2 CACNA1C SYNM MXRA8 COL18A1	7.83e-06	200	223	8	362706445edb33b313684efe50b1f44f5f816e67
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SYNPO2 SPEG HMCN2 CACNA1H ADGRL3 CACNA1C SYNM COL18A1	7.83e-06	200	223	8	a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCell	Biopsy_Other_PF-Mesenchymal-Smooth_Muscle_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	SYNPO2 SPEG LAMC3 HRC CACNA1H SYNM MXRA8 COL18A1	7.83e-06	200	223	8	55ac281901309e30978da1f7489386e54489721e
ToppCell	Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	LAMC3 RFTN1 CACNA1H NCK2 SYNM MXRA8 COL18A1 LPL	7.83e-06	200	223	8	38c21ec379005f688df33aea65237a063c476c2e
ToppCell	proximal-3-mesenchymal-Airway_Smooth_Muscle\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SYNPO2 SPEG HRC CACNA1H ADGRL3 SYNM EMILIN1 COL18A1	7.83e-06	200	223	8	e9a008bfe336002218c63d1c2231986e1b237621
ToppCell	proximal-mesenchymal-Airway_Smooth_Muscle\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SYNPO2 SPEG HRC CACNA1H ADGRL3 SYNM EMILIN1 COL18A1	7.83e-06	200	223	8	5eeb8eb3fe74f5a8055c52ec77e38237bb63ed90
ToppCell	Adult-Immune-enucleated_erythrocyte-D175\|Adult / Lineage, Cell type, age group and donor	APC2 HMCN2 SUPT5H TRIM72 COL7A1 MKX SLC4A10	1.18e-05	152	223	7	530d5427d8617dcb223d807b73abee0ef89285f3
ToppCell	PND01-Immune-Immune_Myeloid-DC\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACAP1 NAGLU C15orf39 RFTN1 SH3TC1 SAMD10 CST3	1.18e-05	152	223	7	c8faa83dcaddb2ce2bb890f90dd8e676f7dcb1b3
ToppCell	PND01-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACAP1 NAGLU C15orf39 RFTN1 SH3TC1 SAMD10 CST3	1.18e-05	152	223	7	c3f00beb8b6fde99263d5ed6bbe3c2415d02f91d
ToppCell	PND01-Immune-Immune_Myeloid-DC-cDC2\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACAP1 NAGLU C15orf39 RFTN1 SH3TC1 SAMD10 CST3	1.18e-05	152	223	7	cefc0ab592e99badf145fb95adf9906cb81be81c
ToppCell	COVID-19_Mild-Neu_0\|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients	MXD3 SLC12A9 DHRS12 ZFHX3 ZC3HAV1	1.59e-05	63	223	5	1ab77b6f098686bc168427159282bbf3538d4292
ToppCell	RV-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	HIP1 EPPK1 CACNA1H ADGRL3 CACNA1C COL18A1 ZFHX3	1.64e-05	160	223	7	29c9b4770d0e73d59cffc7937b179484c76b6dcc
ToppCell	Mild-Lymphoid-NK-innate_T\|Mild / Condition, Lineage, Cell class and cell subclass	ACAP1 TC2N TTC22 NCK2 MRI1 WNT1 CNNM3	1.78e-05	162	223	7	bd218e41b2eadc3bba4c7ac3e34a014f6ad8b1bf
ToppCell	COVID-CD8-memory_CD4\|COVID / Condition, Cell_class and T cell subcluster	DNAJC9 CHPF SYNM ANKEF1 SLC4A10 UNK DOP1A	1.78e-05	162	223	7	22b2a32217d357146c117e618813d451510a1801
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SYNPO2 SPEG CACNA1H ADGRL3 CACNA1C ITGA10 DCHS1	1.85e-05	163	223	7	8f24cef152f5965727bbeee116bd26c75cbba82a
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MXD3 TAOK2 RAD54L CCHCR1 HSPG2 TERF2 C1orf115	1.85e-05	163	223	7	3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TTC36 LAMC3 LURAP1 MFSD9 GJC2 C1orf167 SHROOM2	1.92e-05	164	223	7	d167c7a987b9b35d1e7725c803df4f9cd5380e47
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D175\|Adult / Lineage, Cell type, age group and donor	SYNPO2 SPEG HMCN2 CACNA1C LURAP1 ITGA10 COL18A1	2.16e-05	167	223	7	c4e321bb87512ea839f324c92c0f1afea891483f
ToppCell	droplet-Pancreas-Exocrine-18m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMC3 TSTD1 FBLN2 FAM181B HSPG2 COL18A1 PROSER2	2.33e-05	169	223	7	53690d6f9712b54aa99a0408aae930d64ae478e5
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWA5B2 NOL4 GPR179 AJM1 PKLR ADGRL3 JPH3	2.42e-05	170	223	7	941d637cf76918ee4b0a1833abd1a42593cb8b1a
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DCHS2 LAMC3 COL7A1 SYNM ITGA10 COL18A1 KANK3	2.52e-05	171	223	7	a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34
Drug	Methamphetamine	ATXN2L MAOA CDHR2 SPEG INPPL1 PDYN MRPL43 PEX6 MAPK8IP3 TAOK2 SGCZ FCGBP SLC12A9 PTPRS SUPT5H PKM HRC PLCD1 PLEC RAD54L CACNA1C CCHCR1 HSPG2 LURAP1 RHBDF1 PHRF1 CASP2 UBA2 PLCD3 PPP3R2 KANK3 RBM5 UNK MACF1	6.57e-07	1401	220	34	ctd:D008694
Drug	Heliotrine [303-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A	MXD3 ATXN2L MAPK8IP3 TAOK2 TDRD3 PTPRS CACNA1H RASAL1 POMT2 CASP2 RAB11FIP3	3.46e-06	196	220	11	4739_DN
Drug	Paclitaxel [33069-62-4]; Down 200; 4.6uM; PC3; HT_HG-U133A	PEX6 FARSA PKM MFN2 PLEC ALDH1B1 FLOT2 CASP2 MACF1 IL4R	1.77e-05	191	220	10	6720_DN
Drug	haloperidol; Down 200; 10uM; HL60; HT_HG-U133A	ATXN2L SMC1A PEX6 PTPRS CHPF MVP RHBDF1 MFSD9 BAHD1 IL4R	2.12e-05	195	220	10	6163_DN
Drug	Mesoridazine besylate [32672-69-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	NAGLU C15orf39 TDRD3 CHST7 POMT2 CASP2 PEX26 TNFAIP2 KIF1C ZC3HAV1	2.21e-05	196	220	10	2874_DN
Drug	Tremorine dihydrochloride [300-68-5]; Up 200; 15uM; MCF7; HT_HG-U133A	MXD3 SMC1A MAPK8IP3 PLEC ALDH1B1 CHST7 PEX26 DHRS12 ZFHX3 TNFAIP2	2.21e-05	196	220	10	6273_UP
Drug	Labetalol hydrochloride [32780-64-6]; Down 200; 11uM; MCF7; HT_HG-U133A	MXD3 MAPK8IP3 SLC12A9 PLEC RASAL1 HSPG2 ITGA10 PEX26 KIF1C ZC3HAV1	2.21e-05	196	220	10	3167_DN
Drug	prochlorperazine dimaleate salt; Down 200; 10uM; HL60; HT_HG-U133A	ACAP1 NAGLU TDRD3 PLEC RAD54L COL7A1 FLOT2 CASP2 ZC3HAV1 RAB11FIP3	2.21e-05	196	220	10	1156_DN
Drug	Zaprinast [37762-06-4]; Up 200; 14.8uM; MCF7; HT_HG-U133A	ATXN2L SMC1A LAMC3 TAOK2 PLCD1 ALDH1B1 MVP HSPG2 CASP2 RAB11FIP3	2.31e-05	197	220	10	5349_UP
Drug	Nitrarine dihydrochloride [20069-05-0]; Down 200; 10.6uM; HL60; HT_HG-U133A	TDRD3 PTPRS MFN2 PLCD1 ALDH1B1 IFT27 CASP2 MFSD9 ARSB TNFAIP2	2.41e-05	198	220	10	2188_DN
Drug	Drofenine hydrochloride [548-66-3]; Up 200; 11.4uM; HL60; HT_HG-U133A	MAOA SMC1A TAOK2 SLC17A7 GPRC5D HSPG2 SYNM SLC12A4 MYH14 KIF1C	2.41e-05	198	220	10	2714_UP
Drug	Gemfibrozil [25812-30-0]; Up 200; 16uM; HL60; HG-U133A	ACAP1 HIP1 NAGLU PLCD1 ACBD3 PRRC2B CASP2 IRGQ TNFAIP2 ZC3HAV1	2.41e-05	198	220	10	1430_UP
Drug	Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; HL60; HT_HG-U133A	MAOA PGGT1B TAOK2 SLC17A7 PLCD1 ALDH1B1 CHPF MVP ADGRL3 RASAL1	2.52e-05	199	220	10	2205_UP
Drug	Leucomisine [17946-87-1]; Up 200; 16.2uM; PC3; HT_HG-U133A	NAGLU PEX6 C15orf39 PRRC2B POMT2 COL7A1 ITGA10 MFSD9 SHROOM2 IL4R	2.52e-05	199	220	10	7125_UP
Drug	Proparacaine hydrochloride [5875-06-9]; Up 200; 12uM; HL60; HT_HG-U133A	ATXN2L DCHS2 SMC1A KCNE5 TDRD3 KCNH1 ADGRL3 HSPG2 IFT27 COL7A1	2.52e-05	199	220	10	3113_UP
Drug	Levopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; MCF7; HT_HG-U133A	MXD3 ATXN2L SMC1A HNRNPU MAPK8IP3 SLC12A9 ALDH1B1 BAHD1 CEP170B RAB11FIP3	2.52e-05	199	220	10	3543_DN
Drug	Cefsulodin sodium salt [52152-93-9]; Up 200; 7.2uM; MCF7; HT_HG-U133A	MAOA KCNE5 MAPK8IP3 PTPRS SLC17A7 DHRS12 MYH14 LPL AHNAK2 RAB11FIP3	2.63e-05	200	220	10	3328_UP
Drug	methyl chlorotetrolate	FARSA PKLR PKM	3.03e-05	7	220	3	CID000189115
Drug	neoxaline	ACHE PKLR PKM	4.81e-05	8	220	3	CID006440491
Drug	ChEs	ACHE PKM HSPG2 CAPS AATF	5.75e-05	43	220	5	CID000066898
Drug	thapsigargin; Down 200; 0.1uM; PC3; HT_HG-U133A	MXD3 MVP HSPG2 SYNM VSIG10 SHROOM2 COL18A1 ZC3HAV1 RAB11FIP3	6.40e-05	179	220	9	7103_DN
Drug	Niclosamide [50-65-7]; Down 200; 12.2uM; PC3; HG-U133A	MAOA FADD SLC12A9 UBR2 SYNM CUTC RBM5 DOP1A ZC3HAV1	8.59e-05	186	220	9	1916_DN
Drug	2-Phosphoglycolic Acid	PKLR PKM	9.29e-05	2	220	2	DB02726
Drug	N-methyltaurine	PKLR PKM	9.29e-05	2	220	2	CID000007882
Drug	NPCMD	PKLR PKM	9.29e-05	2	220	2	CID000126341
Drug	BW A440C	PKLR PKM	9.29e-05	2	220	2	CID003086296
Drug	3-(fluoromethyl)phosphoenolpyruvate	PKLR PKM	9.29e-05	2	220	2	CID006443899
Drug	SENP	PKLR PKM	9.29e-05	2	220	2	CID003082911
Drug	8-BDB-TATP	PKLR PKM	9.29e-05	2	220	2	CID003082732
Drug	ITCA	F2 PIK3C2A	9.29e-05	2	220	2	CID003082721
Drug	AC1Q6SAF	PKLR PKM	9.29e-05	2	220	2	CID000194977
Drug	Adenosine 5'-monophosphate 1-oxide	PKLR PKM	9.29e-05	2	220	2	CID000492161
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	ATXN2L TAOK2 SLC12A9 PTPRS RASAL1 COL7A1 RHBDF1 OGFOD3 ARSB	9.32e-05	188	220	9	6195_DN
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	NAGLU C15orf39 TDRD3 MFN2 VSIG10 MYH14 SHARPIN IL4R ZC3HAV1	1.05e-04	191	220	9	1080_UP
Drug	Alverine citrate salt [5560-59-8]; Down 200; 8.4uM; PC3; HT_HG-U133A	HIP1 PRSS16 SMC1A PEX6 MVP POMT2 MFSD9 OGFOD3 ZFHX3	1.14e-04	193	220	9	6345_DN
Drug	Acetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A	SMC1A TDRD3 PLEC IFT27 FLOT2 MFSD9 OGFOD3 TNFAIP2 RAB11FIP3	1.18e-04	194	220	9	1707_DN
Drug	Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; PC3; HT_HG-U133A	DCHS2 ACAP1 ACHE TAOK2 RASAL1 CASP2 LPL TNFAIP2 JPH3	1.18e-04	194	220	9	6644_UP
Drug	AC1L9732	NAGLU COL7A1 PCDHB10 PCDHB9 COL18A1 DCHS1 TNFAIP2	1.23e-04	114	220	7	CID000439300
Drug	Meptazinol hydrochloride [59263-76-2]; Up 200; 14.8uM; HL60; HT_HG-U133A	ATXN2L SMC1A KCNE5 TAOK2 SLC17A7 PLCD1 COL7A1 KIF1C RAB11FIP3	1.23e-04	195	220	9	2906_UP
Drug	Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; MCF7; HT_HG-U133A	MAPK8IP3 TAOK2 TDRD3 SLC12A9 CHST7 MVP RASAL1 POMT2 HSPG2	1.23e-04	195	220	9	2852_DN
Drug	Meclozine dihydrochloride [1104-22-9]; Down 200; 8.6uM; HL60; HT_HG-U133A	SMC1A PGGT1B MAPK8IP3 CHPF ADGRL3 RHBDF1 PEX26 DHRS12 SHARPIN	1.28e-04	196	220	9	2424_DN
Drug	Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A	HIP1 MAOA WDR33 SMC1A MAPK8IP3 CHPF COL7A1 SHROOM2 TNFAIP2	1.28e-04	196	220	9	7269_UP
Drug	Butylparaben [94-26-8]; Down 200; 20.6uM; HL60; HT_HG-U133A	ACAP1 MAOA PGGT1B MAPK8IP3 SLC12A9 ALDH1B1 MLPH MYH14 CEP170B	1.28e-04	196	220	9	3069_DN
Drug	Etofylline [519-37-9]; Down 200; 17.8uM; PC3; HT_HG-U133A	HIP1 PRSS16 PEX6 PLCD1 PRRC2B POMT2 CASP2 COL18A1 RAB11FIP3	1.33e-04	197	220	9	2093_DN
Drug	Aminocaproic acid [60-32-2]; Down 200; 30.4uM; HL60; HT_HG-U133A	HIP1 PGGT1B TAOK2 PLEC MLPH RASAL1 CASP2 VSIG10 RBM5	1.33e-04	197	220	9	3122_DN
Drug	LY 294002; Down 200; 0.1uM; HL60; HT_HG-U133A	MXD3 ATXN2L SMC1A MAPK8IP3 TDRD3 PRRC2B BAHD1 TNFAIP2 IL4R	1.33e-04	197	220	9	6175_DN
Drug	0198306-0000 [212631-61-3]; Up 200; 10uM; PC3; HT_HG-U133A	MXD3 MAOA PGGT1B SH3TC1 ALDH1B1 POMT2 OGFOD3 CEP170B ZC3HAV1	1.33e-04	197	220	9	7069_UP
Drug	Levopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; MCF7; HT_HG-U133A	MXD3 SMC1A INPPL1 MAPK8IP3 ALDH1B1 BRD1 CASP2 MFSD9 BAHD1	1.33e-04	197	220	9	5503_DN
Drug	haloperidol; Up 200; 10uM; PC3; HT_HG-U133A	NAGLU PEX6 PGGT1B IFT27 IRGQ PEX26 COL18A1 IL4R RAB11FIP3	1.38e-04	198	220	9	1203_UP
Drug	Vigabatrin [60643-86-9]; Down 200; 31uM; PC3; HT_HG-U133A	MAOA SPEG TDRD3 PLEC PRRC2B OGFOD3 IRGQ IL4R ZC3HAV1	1.38e-04	198	220	9	6314_DN
Drug	Guaifenesin [93-14-1]; Down 200; 20.2uM; MCF7; HT_HG-U133A	ATXN2L HNRNPU TDRD3 SH3TC1 PLCD1 FKRP CASP2 DHRS12 IL4R	1.38e-04	198	220	9	3897_DN
Drug	Ketoprofen [22071-15-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A	ATXN2L TAOK2 SLC12A9 PTPRS IFT27 FLOT2 BAHD1 DHRS12 TNFAIP2	1.38e-04	198	220	9	2316_DN
Drug	Oxybutynin chloride [1508-65-2]; Up 200; 10.2uM; PC3; HT_HG-U133A	SPEG SMC1A MVP POMT2 CASP2 MFSD9 PEX26 ZFHX3 ZC3HAV1	1.38e-04	198	220	9	7126_UP
Drug	Rifampicin [13292-46-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A	ATXN2L SPEG RASIP1 TDRD3 PLCD1 HSPG2 FKRP CASP2 AHNAK2	1.38e-04	198	220	9	4126_UP
Drug	2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A	PRSS16 SMC1A LAMC3 CHST7 WNT1 CASP2 GJC2 OGFOD3 ARSB	1.38e-04	198	220	9	6969_UP
Drug	br8ADP	F2 PKLR PKM	1.39e-04	11	220	3	CID000447236
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	MXD3 SPEG SMC1A INPPL1 MAPK8IP3 CHPF HSPG2 FLOT2 TNFAIP2	1.44e-04	199	220	9	4526_DN
Drug	Flucytosine [2022-85-7]; Down 200; 31uM; HL60; HT_HG-U133A	MKRN3 MXD3 WDR33 PEX6 TDRD3 ALDH1B1 ADGRL3 MYH14 TNFAIP2	1.44e-04	199	220	9	3073_DN
Drug	Khellin [82-02-0]; Up 200; 15.4uM; MCF7; HT_HG-U133A	TAOK2 TDRD3 SLC17A7 GPRC5D PLCD1 RASAL1 POMT2 FLOT2 PEX26	1.49e-04	200	220	9	1504_UP
Drug	Benzonatate [104-31-4]; Down 200; 6.6uM; PC3; HT_HG-U133A	EPPK1 SPEG SMC1A MAPK8IP3 POMT2 OGFOD3 BAHD1 PEX26 IL4R	1.49e-04	200	220	9	6334_DN
Drug	Cefotetan [69712-56-7]; Down 200; 7uM; PC3; HT_HG-U133A	MXD3 WDR33 PEX6 HNRNPU MAPK8IP3 PLCD1 ADGRL3 HSPG2 MYH14	1.49e-04	200	220	9	3997_DN
Drug	AC1L9LMC	HRC PLEC MLPH APLP2 ARSB LPL	1.54e-04	83	220	6	CID000448113
Disease	Deafness enamel hypoplasia nail defects	PEX6 PEX26	1.51e-04	3	210	2	C1856186
Disease	obesity (implicated_via_orthology)	DCHS2 F2 ALDH1B1 WNT1 ANGPTL6 LPL DCHS1 ZFHX3	1.63e-04	215	210	8	DOID:9970 (implicated_via_orthology)
Disease	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1	POMT2 FKRP	4.97e-04	5	210	2	236670
Disease	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1	POMT2 FKRP	4.97e-04	5	210	2	cv:C4284790
Disease	Walker-Warburg syndrome (is_implicated_in)	POMT2 FKRP	4.97e-04	5	210	2	DOID:0050560 (is_implicated_in)
Disease	resting heart rate	EPPK1 ACHE SPEG SLC12A9 PLEC CACNA1C	7.14e-04	149	210	6	EFO_0004351
Disease	Qualitative or quantitative defects of alpha-dystroglycan	POMT2 FKRP	7.42e-04	6	210	2	cv:C2936406
Disease	Seizures	ACHE SMC1A PDYN APC2 SLC17A7 FKRP MACF1	9.95e-04	218	210	7	C0036572
Disease	caudate nucleus volume	ATXN2L ZFHX3 JPH3	1.25e-03	30	210	3	EFO_0004830
Disease	peroxisomal biogenesis disorder (is_implicated_in)	PEX6 PEX26	1.37e-03	8	210	2	DOID:0080377 (is_implicated_in)
Disease	Muscular Dystrophies, Limb-Girdle	PLEC POMT2 FKRP	1.51e-03	32	210	3	C0686353
Disease	Amphetamine-Related Disorders	ACHE PDYN SGCZ CCHCR1	2.04e-03	75	210	4	C0236733
Disease	Amphetamine Abuse	ACHE PDYN SGCZ CCHCR1	2.04e-03	75	210	4	C0236807
Disease	Amphetamine Addiction	ACHE PDYN SGCZ CCHCR1	2.04e-03	75	210	4	C0236804
Disease	Abnormality of nervous system morphology	APC2 MAPK8IP3	2.18e-03	10	210	2	C4022810
Disease	autoimmune hepatitis (is_marker_for)	F2 ZFHX3	2.66e-03	11	210	2	DOID:2048 (is_marker_for)
Disease	PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	PEX6 PEX26	2.66e-03	11	210	2	C4721541
Disease	Epilepsy, Cryptogenic	SMC1A HNRNPU KCNH1 SLC4A10	2.83e-03	82	210	4	C0086237
Disease	Awakening Epilepsy	SMC1A HNRNPU KCNH1 SLC4A10	2.83e-03	82	210	4	C0751111
Disease	Aura	SMC1A HNRNPU KCNH1 SLC4A10	2.83e-03	82	210	4	C0236018
Disease	type 2 diabetes mellitus (is_marker_for)	F2 PIK3C2A MFN2 LPL CST3	2.95e-03	136	210	5	DOID:9352 (is_marker_for)
Disease	Congenital muscular dystrophy	POMT2 FKRP	3.17e-03	12	210	2	cv:C0699743
Disease	Profound Mental Retardation	NAGLU PEX6 CASP2 COL18A1 SLC4A10	3.24e-03	139	210	5	C0020796
Disease	Mental Retardation, Psychosocial	NAGLU PEX6 CASP2 COL18A1 SLC4A10	3.24e-03	139	210	5	C0025363
Disease	Mental deficiency	NAGLU PEX6 CASP2 COL18A1 SLC4A10	3.24e-03	139	210	5	C0917816
Disease	volumetric bone mineral density	FHAD1 CACNA1C VSIG10	3.33e-03	42	210	3	EFO_0007620
Disease	Zellweger Spectrum	PEX6 PEX26	3.73e-03	13	210	2	C3658299
Disease	survival time, breast carcinoma	ZFHX3 PROSER2	3.73e-03	13	210	2	EFO_0000305, EFO_0000714
Disease	Zellweger-Like Syndrome	PEX6 PEX26	3.73e-03	13	210	2	C0751594
Disease	hyperglycemia (is_marker_for)	F2 HSPG2	3.73e-03	13	210	2	DOID:4195 (is_marker_for)
Disease	Infantile Refsum Disease (disorder)	PEX6 PEX26	3.73e-03	13	210	2	C0282527
Disease	homocysteine measurement	DCHS2 MFN2 C1orf167	4.31e-03	46	210	3	EFO_0004578
Disease	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K	POMT2 FKRP	4.34e-03	14	210	2	C1836373
Disease	alpha-Dystroglycanopathies	POMT2 FKRP	4.34e-03	14	210	2	C2936406
Disease	Fukuyama Type Congenital Muscular Dystrophy	POMT2 FKRP	4.34e-03	14	210	2	C0410174
Disease	Muscle eye brain disease	POMT2 FKRP	4.34e-03	14	210	2	C0457133
Disease	Autosomal recessive limb-girdle muscular dystrophy	PLEC FKRP	4.34e-03	14	210	2	cv:C2931907
Disease	Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies) Type A, 1	POMT2 FKRP	4.34e-03	14	210	2	C4284790
Disease	Intellectual Disability	APC2 NAGLU PEX6 HNRNPU MAPK8IP3 CASP2 COL18A1 SLC4A10 MACF1	4.95e-03	447	210	9	C3714756
Disease	Walker-Warburg congenital muscular dystrophy	POMT2 FKRP	4.98e-03	15	210	2	C0265221
Disease	Peroxisome biogenesis disorders	PEX6 PEX26	4.98e-03	15	210	2	C1832200
Disease	Adrenoleukodystrophy, Neonatal	PEX6 PEX26	4.98e-03	15	210	2	C0282525
Disease	late-onset Alzheimers disease	PTPRS SELENOO NCK2 OPLAH RHBDF1 CFAP74 JPH3	5.09e-03	292	210	7	EFO_1001870
Disease	5-oxoproline measurement	OPLAH SHARPIN	5.66e-03	16	210	2	EFO_0010988
Disease	Zellweger Syndrome	PEX6 PEX26	5.66e-03	16	210	2	C0043459
Disease	muscular dystrophy (is_implicated_in)	POMT2 FKRP	6.39e-03	17	210	2	DOID:9884 (is_implicated_in)
Disease	Night blindness, congenital stationary	GPR179 CACNA2D4	6.39e-03	17	210	2	C0339535
Disease	alpha-L-iduronidase measurement	UVSSA NKX1-1	6.39e-03	17	210	2	EFO_0020139
Disease	Ischemic stroke, fibrinogen measurement	ATXN2L PLEC JPH3	7.10e-03	55	210	3	EFO_0004623, HP_0002140

Protein segments in the cluster

Peptide	Gene	Start	Entry
AEGREDAELLVTVRG	ACHE	31	P22303
SDDADGGRGREISRD	ARID3B	191	Q8IVW6
ERGAEGAAEAEGVRR	ERICH3	836	Q5RHP9
ARREVDSIGLEEASG	BRD1	666	O95696
EAVVGAAERFRARTG	AKT1S1	11	Q96B36
GAGRSQEEARLVEEA	C1orf167	46	Q5SNV9
RDGSRSLDADEFRQG	CAPS	121	Q13938
GHVAEGDRADVDRAV	ALDH1B1	66	P30837
LRFGARVDGRSEEEE	ASB10	201	Q8WXI3
QRDADIGVAEAERDA	FLOT2	176	Q14254
IGVAEAERDAGIREA	FLOT2	181	Q14254
LGSGREDDAIVLDDA	ADGRL3	1271	Q9HAR2
QDGEAGRRAREVAFI	AJM1	886	C9J069
LAADVGKAGAEREFR	SLC25A5	141	P05141
REAFAVLDRGDGSIS	ANKEF1	341	Q9NU02
DRTDDIDRELSEGQG	DOP1A	611	Q5JWR5
EAEEAGAALRTARAG	ACAP1	151	Q15027
RRVIDVFDTDGDGEV	PPP3R2	56	Q96LZ3
EERRRSGDLAAQAAE	ANKRD35	876	Q8N283
AAELGRARDAAEARV	ANKRD24	871	Q8TF21
VIRGDRDESDDGGVA	CEP170B	611	Q9Y4F5
RGRGRTEGDEEAAAI	C1orf115	21	Q9H7X2
GADDRIREFSLAGGI	ATXN2L	1041	Q8WWM7
AAGDEAREAAAVRAL	NAGLU	21	P54802
EEEAALVERRRAGEG	ANO8	556	Q9HCE9
LGAVTEEEAARLRAG	ANKRD63	261	C9JTQ0
FLDRLVDVDGDEAGV	RASAL1	541	O95294
GREEARRLEQEAFGA	RASIP1	256	Q5U651
RRLEQEAFGAADSEG	RASIP1	261	Q5U651
KSGAEVEAGDAAERR	RAVER1	16	Q8IY67
EDAGSREFREVSEAV	HSPG2	101	P98160
ENSRDVFIDSGGVRR	C9orf64	16	Q5T6V5
DAAASEADRQLGEER	RAD54L	366	Q92698
ARDGDAEEVRELGTV	RFTN1	561	Q14699
RLRAVFDALDGDGDG	RAB11FIP3	206	O75154
TGEVRTARALGDRDA	PCDHGB4	621	Q9UN71
SGRRVDGLAFVNEDI	LRWD1	496	Q9UFC0
FNAERVGGLEEERES	APLP2	666	Q06481
EGAVEAGERAAREVL	MAOA	446	P21397
SGRGSAEAAEDDEIR	DCHS1	3031	Q96JQ0
ADDGVAEVLARRGEV	OGFOD3	66	Q6PK18
AGAAERERLRADSLD	MXD3	141	Q9BW11
DVDEGADLLGEFSVR	MAPK8IP3	396	Q9UPT6
GEATGEAVREDRVTL	JSRP1	216	Q96MG2
ERGVEGDFLIRDSES	NCK2	301	O43639
EAEAADSGAVGARRF	MFSD9	31	Q8NBP5
AGAGEERALGAEAIR	GPR179	1711	Q6PRD1
READEGLLRAGENDF	KMT5C	146	Q86Y97
QALRDGAAAGDRDRD	GJC2	356	Q5T442
FEILSREEEARGGVT	HMCN2	2751	Q8NDA2
RDAGSRDEKAEAGEA	ASMTL	251	O95671
ADAEAAAGSQAEGRR	KCNE5	111	Q9UJ90
VVRGSDRDGAADGLS	DSG4	236	Q86SJ6
LRRAGVAEAEGEACA	CCDC194	161	A0A1B0GVG4
EEESGLRGFARELDS	TMEM63C	776	Q9P1W3
GTAGESLDRAGAERV	MBD3L5	121	A6NJ08
EAEAFAIGARARAEA	FLOT1	321	O75955
EERAEAGARAEAGAR	FBLN2	321	P98095
AGALEAGEEARRRAA	MYH14	1401	Q7Z406
AGEEARRRAAREAEA	MYH14	1406	Q7Z406
GAVLFEDGGASERER	MKX	11	Q8IYA7
SRGGVAAADQRRDFI	LPL	21	P06858
GIRSSRLEEDDGDVA	NXF1	46	Q9UBU9
RDEKAEGIARSADAG	PIK3C2A	1536	O00443
RGLSDGFREGAESEL	PDYN	131	P01213
LDDFGSENEGELRAR	PDZD4	231	Q76G19
VVGSAAFGEERRLDV	PEX26	181	Q7Z412
LGDVRVRSRAGFESE	PDE7A	66	Q13946
VDLLGRDRDGLGEDA	PEX6	531	Q13608
GDARELLREETGAAL	COL18A1	671	P39060
ERLQAALDDEEAGGR	HNRNPU	36	Q00839
DIGEDLFSEALGRAV	GHDC	396	Q8N2G8
GTAGESLDRAGAERV	MBD3L2B	121	A0A1B0GVZ6
RGAVAAEGASDTERE	PHRF1	906	Q9P1Y6
SEEGARGAEVEDLRA	KIF1C	821	O43896
RLAAERGGRDLDDLD	KCNH1	751	O95259
AGGERARTEVDVAAT	LURAP1	176	Q96LR2
GVRRFDEILEASDGI	PKM	276	P14618
ADDVDRRVQFGIESG	PKLR	526	P30613
DAGEAARARGAVLRA	GOLGA6L2	886	Q8N9W4
GEAAAGGAAEEARRL	ACBD3	61	Q9H3P7
LSGAEGGDVREATRD	FAM181B	51	A6NEQ2
TRVAAVDADDGENAR	PCDH10	601	Q9P2E7
EGELAARGTRVVSDD	PCDHB10	56	Q9UN67
VGELAERGARVVSED	PCDHB15	56	Q9Y5E8
GDEAELGAVRETSRR	MRGPRE	291	Q86SM8
DRVFEQGGARVVVDS	ISCA2	96	Q86U28
RSRLETRAGEEDEGE	NBAS	456	A2RRP1
EERRESAAADAGFAL	RBM5	571	P52756
AESRAEAARIEGEGS	MVP	726	Q14764
AEGGRIAQSAELADR	MACF1	5406	Q9UPN3
GTAGESLDRAGAERV	MBD3L3	121	A6NE82
DDESGAGELTREELR	MCM7	311	P33993
VDELGVVDRSQAGDR	MFN2	286	O95140
AARSRGGLGEEAAEV	PTPRS	906	Q13332
RQLIGRVEASDADAG	DCHS2	2896	Q6V1P9
RVEASDADAGIDGVI	DCHS2	2901	Q6V1P9
RVEIDRTFAEAAGSG	PLCD1	211	P51178
VRVLARDIDAGNFGS	PCDHB4	261	Q9Y5E5
DESGACVIDRDGRLF	KCTD18	51	Q6PI47
RTRDLGGGAAIDDIE	MALRD1	1656	Q5VYJ5
RERGEEAAGSDRASD	APC2	1666	O95996
REVASVRARDDDSGN	CDHR2	946	Q9BYE9
ASGREGEAERGEARA	FHAD1	656	B1AJZ9
DLAGRRAVDSAEARA	IFT27	126	Q9BW83
SRDDFQEGREGIVAR	IL4R	391	P24394
SAASEDDIFRRAGGL	CACNA1C	1736	Q13936
LSRARDSDGAEEDVA	GPRC5D	296	Q9NZD1
ALAEAEEGQRRVEGA	CROCC2	1416	H7BZ55
RDEDGDALAEREAAG	FAM241A	16	Q8N8J7
SRGLQAGDVVEFEVR	FCGBP	286	Q9Y6R7
RETGRFLGEVDGAVL	CACNA2D4	906	Q7Z3S7
DELREARFAAGVAEQ	FAM131C	141	Q96AQ9
RSREELDELTGEVAG	FEM1A	26	Q9BSK4
LRRVDDFEAGAAAGA	FADD	76	Q13158
ARFGDRLRSEAQGAD	DHRS12	246	A0PJE2
RLENVAGPRSADEAD	BAHD1	76	Q8TBE0
RLAAADGAVAGEVRA	ANGPTL6	81	Q8NI99
ALARAEKAGRAEAEG	CCHCR1	131	Q8TD31
RVGEGDKEDATRRFQ	DNAJC9	46	Q8WXX5
GEEAATAAREREPAS	FIZ1	386	Q96SL8
EEEAARESAARPAAG	FBXW4	11	P57775
FGRSVDGRLDLDGDD	ITGA10	611	O75578
RCALDFRDGEEVATG	ARSB	191	P15848
ESAVNAERGGADRIE	CUTC	36	Q9NTM9
EAREAAEEAAAGARA	KANK3	381	Q6NY19
AEEAAAGARAQLREA	KANK3	386	Q6NY19
QLDAAGDRLELRSEG	C2orf81	276	A6NN90
GEAALTEDDIRGFVR	COL7A1	2781	Q02388
TESEERFRGLEEGQA	EMILIN1	701	Q9Y6C2
EQLRGAEAGSVVDER	FKRP	376	Q9H9S5
RDGVLDVEARRQGAA	HELZ2	1381	Q9BYK8
AERGAELGADEEQRV	CACNA1H	56	O95180
REEFTVLGRQVEDAG	FIBIN	81	Q8TAL6
REGGAEESAIRVGFV	SEC24C	536	P53992
FIQACRGDETDRGVD	CASP2	316	P42575
RLEAEGTVALGRAGD	C2CD4A	241	Q8NCU7
REAAAAREEAEQALG	CCDC153	121	Q494R4
DASVEEEGVRRALDF	CST3	41	P01034
EAFRTADREEVEATG	CFAP74	181	Q9C0B2
ERGEAAAFDLRQESG	DHRS13	71	Q6UX07
GAGVRTEADVEEEAL	MLPH	371	Q9BV36
AAELEAVREAFETGG	IRGQ	191	Q8WZA9
GTAGESLDRAGAERV	MBD3L4	121	A6NDZ8
GTAGESLDRAGAERV	MBD3L2	121	Q8NHZ7
EGELAARGTRVVSDD	PCDHB9	56	Q9Y5E1
ALRARFGVASGDRAE	KCTD11	136	Q693B1
DERLAGSGEGERLDF	PGGT1B	6	P53609
VVGRSEAEAREVAAE	VARS2	551	Q5ST30
DGASSRGAREFVERE	MRPL43	36	Q8N983
EGGERRRTEALGDAE	UVSSA	386	Q2YD98
RGRIRSEDEEDLGNA	TDRD3	251	Q9H7E2
ARAAGRDVAAEAVAR	POMT2	26	Q9UKY4
LRRLEASDGGLDSAE	FARSA	11	Q9Y285
EERAARGRLDAELGA	SYNM	101	O15061
LEELEGSARASFGDR	TC2N	96	Q8N9U0
APETEAARGAEEARG	NKX1-1	201	Q15270
FAGRGSSEEARREAL	PROSER2	411	Q86WR7
GGDGVTRELLFREEA	OPLAH	1176	O14841
RLSGEAAEAEDLGFG	FSD2	121	A1L4K1
SRAAREELLAEFGSG	EPPK1	2546	P58107
RRGVGAGLEAAERES	HIP1	21	O00291
AASAERLREGLEAGT	MED24	136	O75448
EAEAGRSRGQEIETI	NANOGNB	16	Q7Z5D8
RGRAFRVADDTAEGL	RHBDF1	161	Q96CC6
DAEATEADGADGRQR	SELENOO	636	Q9BVL4
ARAGRDGSFLVRDSE	INPPL1	36	O15357
ERLAEAETRAADGGR	SHROOM2	11	Q13796
AETRAADGGRLVEVQ	SHROOM2	16	Q13796
EREELAGSLARAIAG	SHARPIN	171	Q9H0F6
RELEAQRAGFGAEAE	TAOK2	526	Q9UL54
AGAVRAGFGERRDVD	SAMD10	16	Q9BYL1
EEELTGRLAQARGAA	SH3TC1	536	Q8TE82
EAEARARASNEDGDI	UBA2	221	Q9UBT2
RDLADVAAREAEREG	MRI1	101	Q9BV20
VAAREAEREGATEEA	MRI1	106	Q9BV20
RDGAARGTSDERAAQ	PPP1R26	56	Q5T8A7
RQEGAETLELSADGR	SLC17A7	26	Q9P2U7
EVRASEDGRVLFSAD	SGCZ	141	Q96LD1
GEEAEVDEERRSAAG	SUPT5H	21	O00267
RRARDDGQADSEVLG	RNF169	116	Q8NCN4
DGQADSEVLGECARR	RNF169	121	Q8NCN4
LDRREEAGGASSEEE	HRC	591	P23327
RRRLLDAAFDGDVGE	IQANK1	136	A8MXQ7
DAAFDGDVGEIRAVL	IQANK1	141	A8MXQ7
AQDDRGASREREEGA	SOWAHB	231	A6NEL2
RGAEDLSLNRGDEDE	NOL4	371	O94818
EAESGEGTRRRAAEA	SLC12A4	101	Q9UP95
ATAARVIDRFDEGED	AATF	31	Q9NY61
QGREGEATATADRRE	AHNAK2	611	Q8IVF2
GLVDGGEAVEARLRD	CGN	751	Q9P2M7
AARGRLAAASEQEEE	CHPF	686	Q8IZ52
AAGEREQGAEARAAE	CHST7	61	Q9NS84
VRRQLGDFDTEAGAV	C15orf39	921	Q6ZRI6
ESGSEAERAAARRLE	CNNM3	171	Q8NE01
EEEATNGREGLLRFS	AUP1	161	Q9Y679
GFIGNEEADRLAREG	RNASEH1	266	O60930
AAAAAGGVSEEELVR	TNFAIP2	106	Q03169
AVGRAGRDVGSAELA	ZNF488	61	Q96MN9
VADRGGRSDDEVRVL	ZBTB37	226	Q5TC79
RELRVIQESEAGDAG	SYNPO2	266	Q9UMS6
IGSAAERGFFEAERD	MKRN3	171	Q13064
VGEDEDHRGRRLSDF	SPEG	1586	Q15772
AARSEDGRALSDREE	PLCD3	486	Q8N3E9
GRRAGAGDEADDERS	ARHGAP23	1266	Q9P227
KERTENREEGRFASG	STYXL2	1101	Q5VZP5
REDGAAGDRDLRAAV	TEDC1	436	Q86SX3
VNSGRGDAEAEALAR	SLC12A9	821	Q9BXP2
TRNDEEAVVDRGGTR	SLC4A10	16	Q6U841
DLGENSRVARLGADE	NRDC	71	O43847
SRVARLGADESEEEG	NRDC	76	O43847
RAGGVSAQRDLFEER	PRRC2B	786	Q5JSZ5
FGGRGFEDSRAEDKR	PRRC2B	1266	Q5JSZ5
EEGAEDRTFARVIVG	SMC1A	86	Q14683
LEGSLDREAERVRGE	TRIM72	186	Q6ZMU5
DREAERVRGEAGVAL	TRIM72	191	Q6ZMU5
LRGEAEAARRAAEEA	PLEC	2216	Q15149
RAGEDARVLRDGFAE	NSMCE3	31	Q96MG7
EDDEGDARARARIAL	ZC3H12D	471	A2A288
AEVVSGFEAEAAGRR	VWA5B2	56	Q8N398
AVGDVLRDRFDGASR	WNT1	241	P04628
EDLERAVELSGGRGR	TTC36	106	A6NLP5
AAVGEQEGAREREEL	VSIG10	476	Q8N0Z9
DGLDEDSDRAIEGRT	F2	301	P00734
DVQATGRIADDADPR	ZC3HAV1	471	Q7Z2W4
FDASEEAARGRDLRG	WDR33	1136	Q9C0J8
EAIGFATTVDRDGRR	UBR2	256	Q8IWV8
GERASAAGAECELAR	UNK	686	Q9C0B0
EDSAAAVADRRVGQA	TPGS1	206	Q6ZTW0
GRLGQEEEEEACAAR	TTC22	111	Q5TAA0
VAFAEVERRLRSGGA	PRSS16	246	Q9NQE7
AERGAGEARLEEAVN	TERF2	81	Q15554
VAEGGRRLDFADESA	ZFHX3	581	Q15911
ARLFDVRSREEAAAG	TSTD1	21	Q8NFU3
FSRQVSVDEERGGDI	JPH3	501	Q8WXH2
RQELEEAERVGAGLS	LAMC3	1451	Q9Y6N6
DRVAVGADAFERGDF	MXRA8	241	Q9BRK3